2-Bromo-1H-imidazole-4,5-dicarbonitrile

Catalog No.: 
ACJRPF183
CAS No.: 
50847-09-1
Molecular Formula: 
C5HBrN4
Molecular Weight: 
196.99
2-Bromo-1H-imidazole-4,5-dicarbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$97.00In stockIn stock
5g97%$291.00In stockInquiry
25g97%$1397.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-1H-imidazole-4,5-dicarbonitrile
IUPAC Name2-Bromo-1H-imidazole-4,5-dicarbonitrile
MDL No.MFCD00174288
Molecular FormulaC5HBrN4
Molecular Weight196.99
SMILESBrC1=NC(C#N)=C(N1)C#N
InChI KeyWMPWSWMSTJAAPF-UHFFFAOYSA-N
Synonym2-bromo-1H-imidazole-4,5-dicarbonitrile | 50847-09-1 | 2-bromoimidazole-4,5-dicarbonitrile | 2-bromo-4,5-dicyano-1H-imidazole | 2-bromo-4,5-dicyanoimidazole | MFCD00174288 | 1H-Imidazole-4,5-dicarbonitrile, 2-bromo- | SCHEMBL1220922 | YSCK0285 | DTXSID70381292 | WMPWSWMSTJAA
CAS No.50847-09-1
PubChem CID2779148

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJRPF183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJRPF183 route product structure diagram
    ACJRPF18350847-09-1In Stock
Inquiry

2. ACJRPF183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJRPF183 route product structure diagram
    ACJRPF18350847-09-1In Stock
Inquiry

3. ACJRPF183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJRPF183 route product structure diagram
    ACJRPF18350847-09-1In Stock
Inquiry

Comments (0)